Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers

Recruiting now · Phase 4

Conditions studied: Wound of Skin, Burns

In brief

This study is intended to provide information from subjects who currently have painful, chronically open wounds and assess the pain reduction capacity of KeraStat® Gel with Morphine. In gathering data from subjects who have baseline pain from their chronically open wounds, the investigators can then evaluate the capacity of KeraStat® Gel plus Morphine in reducing the subjects daily pain levels, pain associated with dressing changes, and pain medication consumption.

Key facts

Study ID

NCT05217160

Run by

The Metis Foundation

People needed

24

Starts

2021-05-11

Expected to finish

2022-05-31

Last updated by the study team

2022-02-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects age 18 or older able to provide informed consent.
• Ulcer size 1-300 cm2
• Undermining/tunneling <3 cm from wound margin 5. Grossly free of necrotic and/or infected tissue 6. Baseline minimum of 2 on VAS pain scale

You may not qualify if…

• Subjects who meet any of the following criteria will be excluded from the study:
• Known allergy to the standard of care or any of the ingredients in KeraStat® Gel or to morphine
• Wound has heavy or high-volume exudate or necrotic tissue
• Clinical signs of infection or contamination of the wound
• Subjects unable to complete the VAS pain score in pain journal
• Pregnant or nursing
• Prisoner
• Any condition the Investigator determines will compromise subject safety or prevent the subject from completing the study

Where it is running

• South Texas Aesthetic and Reconstructive Surgery — San Antonio, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.